At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 45 enrolled
Drug / intervention
external beam radiation therapy +2 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ultra-hypofractionated, Image-guided, Intensity-modulated Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
In Brief
A Phase 2 clinical trial evaluating external beam radiation therapy, brachytherapy, and 1 other intervention for Prostate Cancer. Completed, enrolled 45 participants across 6 sites.
Detailed Summary
The purpose of this study is to test the safety and side effects "of "ultra-hypofractionated" radiation therapy when used after brachytherapy (radiation implants). This treatment delivers a higher radiation dose with each treatment over a shorter period of time.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartOct 2014
First PostedOct 2014
Primary CompletionJan 2023
TodayJul 2026
First PostedOct 31, 2014
Enrollment StartOct 28, 2014
Primary CompletionJan 9, 2023
TodayJul 2, 2026
Enrollment to primary: 8.2 yearsPosted 11.7 years ago
Interventions
external beam radiation therapyradiation
brachytherapyradiation
questionnairesbehavioral